Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Use this LXRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LXRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LXRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Lexicon Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full LXRX income, balance, and cash tables.